Biobanking Market Report: Trends, Forecast and Competitive Analysis to 2030

Biobanking Market Report: Trends, Forecast and Competitive Analysis to 2030

Biobanking Trends and Forecast

The future of the global biobanking market looks promising with opportunities in the therapeutics, drug discovery & clinical research, clinical diagnostics, and other markets. The global biobanking market is expected to reach an estimated $xxx billion by 2030 with a CAGR of 7.5% from 2024 to 2030. The major drivers for this market are significant capital allocation to the research and development of cutting-edge therapies, including regenerative medicine, personalized medicine and in-depth studies on cancer genomics and high incidence of chronic diseases.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Biobanking by Segment

The study includes a forecast for the global biobanking by product & service, sample type, application, end use industry, and region.

Biobanking Market by Product & Service [Shipment Analysis by Value from 2018 to 2030]:

• Equipment
• Consumables
• Software
• Services

Biobanking Market by Sample Type [Shipment Analysis by Value from 2018 to 2030]:

• Blood
• Tissue
• Nucleic Acids
• Cell Lines

Biobanking Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Therapeutics
• Drug Discovery & Clinical Research
• Clinical Diagnostics
• Other Applications

Biobanking Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

• Pharmaceutical & Biotechnology Companies and Cros
• Academic & Research Institutes
• Hospitals

Biobanking Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Biobanking Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies biobanking companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the biobanking companies profiled in this report include-

• Thermo Fisher Scientific
• PHC Holdings
• Becton
• Dickinson and Company
• Qiagen
• Greiner Holding
• Bay Biosciences

Biobanking Market Insights

Lucintel forecasts that equipment is expected to witness highest growth over the forecast period due to due to need of wide range of specialized equipments and products essential for the processing, analysis, storage, and transport of biological samples.

Within this market, therapeutics will remain the largest segment due to the growing demand for advanced therapies for the treatment of chronic diseases.

North America is expected to witness highest growth over the forecast perioddue to growing government efforts, including funding and the advancement of the biobanks market in the united states.

Features of the Global Biobanking Market

Market Size Estimates: Biobanking market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Biobanking market size by various segments, such as by product & service, sample type , application, end use industry, and region in terms of ($B).

Regional Analysis: Biobanking market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product & service, sample types , applications, end use industries, and regions for the biobanking market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the biobanking market.

Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q.1 What is the biobanking market size?

Answer: The global biobanking market is expected to reach an estimated $xxx billion by 2030.

Q.2 What is the growth forecast for biobanking market?

Answer: The global biobanking market is expected to grow with a CAGR of 7.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the biobanking market?

Answer: The major drivers for this market are significant capital allocation to the research and development of cutting-edge therapies, including regenerative medicine, personalized medicine and in-depth studies on cancer genomics and high incidence of cronic diseases.

Q4. What are the major segments for biobanking market?

Answer: The future of the biobanking market looks promising with opportunities in the therapeutics, drug discovery & clinical research, clinical diagnostics, and other markets.

Q5. Who are the key biobanking market companies?

Answer: Some of the key biobanking companies are as follows:

• PHC Holdings
• Becton
• Dickinson and Company
• Qiagen
• Greiner Holding
• Bay Biosciences
• Bay Biosciences

Q6. Which biobanking market segment will be the largest in future?

Answer: Lucintel forecasts that equipment is expected to witness highest growth over the forecast period due to due to need of wide range of specialized equipments and products essential for the processing, analysis, storage, and transport of biological samples.

Q7. In biobanking market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast perioddue to growing government efforts, including funding and the advancement of the biobanks market in the united states.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the biobanking market by product & service (equipment, consumables, software, and services), sample type (blood, tissue, nucleic acids, and cell lines), application (therapeutics, drug discovery & clinical research, clinical diagnostics, and other applications), end use industry (pharmaceutical & biotechnology companies and cros, academic & research institutes, and hospitals), and region (North America, Europe, Asia Pacific, and the Rest of the World)?

Q.2. Which segments will grow at a faster pace and why?

Q.3. Which region will grow at a faster pace and why?

Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?

Q.5. What are the business risks and competitive threats in this market?

Q.6. What are the emerging trends in this market and the reasons behind them?

Q.7. What are some of the changing demands of customers in the market?

Q.8. What are the new developments in the market? Which companies are leading these developments?

Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?

Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?

Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Please note: It will take 2-3 business days to deliver the report upon receipt the order.